REG - Hikma Pharmaceutical - Director Declaration

Hikma PharmaceuticalsAnnouncement

29/07/2024 16:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240729:nRSc2662Ya&default-theme=true

RNS Number : 2662Y  Hikma Pharmaceuticals Plc  29 July 2024

Hikma Pharmaceuticals PLC

Director Declaration

LONDON, 29 July 2024: Pursuant to Listing Rule 9.6.14, Hikma Pharmaceuticals
PLC confirms that Victoria Hull, Senior Independent Non-Executive Director,
has been appointed as a Non-Executive Director of IMI plc with effect from 1
August 2024.

- ENDS -

 

Enquiries:

 

 Hikma Pharmaceuticals PLC
 Helen Middlemist           +44 20 7399 2760

 Group Company Secretary

 

Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY)

(LEI: 549300BNS685UXH4JI75)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNRLMATMTMTBRI